| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | Nov 8, 2024 | ||
| SC 13G/A | Report | Oct 21, 2024 | ||
| SC 13G | Report | Sep 30, 2024 | ||
| SC 13G | Report | Feb 16, 2024 | ||
| SC 13G/A | Report | AMENDMENT NO. 2 TO SCHEDULE 13G | Feb 14, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | Jan 23, 2024 | ||
| SC 13G/A | Report | Jan 9, 2024 | ||
| SC 13G | Report | Oct 24, 2023 | ||
| SC 13G/A | Report | ITEOS THERAPEUTICS, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | AMENDMENT NO. 1 TO THE SCHEDULE 13G | Feb 14, 2023 | |
| SC 13G | Report | SCHEDULE 13G | Feb 9, 2023 | |
| SC 13G/A | Report | Jan 26, 2023 | ||
| SC 13G/A | Report | Jan 20, 2023 | ||
| SC 13G | Report | Jul 8, 2022 | ||
| SC 13G | Report | SCHEDULE 13G | May 2, 2022 | |
| SC 13G/A | Report | ITEOS THERAPEUTICS, INC. | Feb 14, 2022 | |
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC OWNS <5% | Feb 10, 2022 | |
| SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS >5% | Feb 12, 2021 | |
| SC 13G | Report | Feb 4, 2021 |